Combined oral contraceptive (monophasic)
Estradiol with nomegestrol
Brand names: Zoely
Adult dose
Dose: 1 tablet OD for 24 days then 4 days placebo
Route: Oral
Frequency: OD (24/4 regimen)
Clinical pearls
- FSRH UKMEC eligibility criteria for prescribing
- 17β-estradiol-based COC with shorter hormone-free interval — reduced withdrawal bleeding
- Quick start permitted with negative pregnancy test
Contraindications
- History of VTE/arterial events
- Migraine with aura
- Breast cancer
- Severe hepatic disease
- Smokers >35 years
- Pregnancy
Side effects
- Breakthrough bleeding
- Headache
- Mood changes
- Acne
- VTE
- Hypertension
Interactions
- CYP3A4 inducers (carbamazepine, rifampicin, ritonavir)
- Antibiotics (enzyme-inducers only — non-enzyme-inducers no interaction per FSRH)
Monitoring
- BP at baseline and annually
- BMI
- Migraine pattern
- VTE risk factors
Reference: BNF; FSRH CHC guideline; UKMEC; https://bnf.nice.org.uk/drugs/estradiol-with-nomegestrol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21